Kestra Medical Technologies, Ltd. (KMTS) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "KMTS"
      ],
      "issuer_cik": "0001877184",
      "owner_cik": "0001877198",
      "accession_number": "0001193125-26-428980",
      "form_type": "4",
      "filing_date": "2026-10-22",
      "period_of_report": "2026-10-21",
      "issuer_name": "KESTRA MEDICAL TECHNOLOGIES, LTD.",
      "issuer_trading_symbol": "KMTS",
      "owner_name": "Umberger Traci S",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "See Remarks",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-21",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 96404,
      "transaction_price_per_share": 27.1493,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 199421,
      "transaction_value": 2617301.1172,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026."
        },
        {
          "id": "F2",
          "description": "The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.8050 to $27.7927. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."
        }
      ],
      "remarks": "General Counsel and Chief Adminstrative Officer"
    },
    {
      "tickers": [
        "KMTS"
      ],
      "issuer_cik": "0001877184",
      "owner_cik": "0001877188",
      "accession_number": "0001193125-26-428976",
      "form_type": "4",
      "filing_date": "2026-10-22",
      "period_of_report": "2026-10-20",
      "issuer_name": "KESTRA MEDICAL TECHNOLOGIES, LTD.",
      "issuer_trading_symbol": "KMTS",
      "owner_name": "Webster Brian Daniel",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "See Remarks",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-20",
      "deemed_execution_date": "2026-10-20",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 13316,
      "transaction_price_per_share": 29.5172,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 446899,
      "transaction_value": 393051.0352,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026."
        },
        {
          "id": "F2",
          "description": "The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $28.8568 to $29.8475. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."
        }
      ],
      "remarks": "President and Chief Executive Officer"
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.